ing a nuclear localization sequence (NLS) near their N GST-HDAC5 substrates, respectively (P Ͻ 0.05; Figure  1D ). Hypertrophic hearts from transgenic mice expresstermini ( Figures 1A and 1B) . To determine whether a kinase specific for these phosphorylation sites might be ing activated calcineurin (Molkentin et al., 1998) also showed pronounced elevation of HDAC kinase activity activated in the heart in response to hypertrophic stimuli, we developed an in vitro kinase assay using portions of ( Figure 1E ). Cardiac hypertrophy due to expression of activated forms of CaMK and the MAP kinase MEK5 in HDAC4, HDAC5, and HDAC9/MITR encompassing the conserved CaMK sites fused to GST as substrates (Fig- the heart also resulted in stimulation of HDAC kinase activity (data not shown).
ure 1C). Phosphorylation of GST-HDAC proteins was readily detected in this assay (Figure 1C, WT). GST-
To further characterize the HDAC kinase, we tested its sensitivity to a panel of inhibitors ( Figure 1F and HDAC fusion proteins in which the CaMK sites (Ser-246 in HDAC4, Ser-259 in HDAC5, and Ser-218 in HDAC9/ data not shown). The HDAC kinase was inhibited by staurosporin and K252a, which are general serine/threo-MITR) were mutated to alanines ( Figure 1C , Mut) were not phosphorylated by cardiac extracts, demonstrating nine kinase inhibitors. The kinase was also partially inhibited by HA1004, which is a broad inhibitor known to that the kinase activity is specific for the CaMK sites.
Constriction of the thoracic aorta in mice creates a inhibit CaMK, PKA, and PKG. However, the kinase was not inhibited by compounds that inhibit CaMK (KN62, pressure gradient in excess of 50 mm Hg and results in approximately a 50% increase in cardiac mass within KN93, or AIP), PKA (H-89 or 4-cyano-3-methylisoquinoline), PKC (GF109203X, Gö 6976, Gö 6983, or Ro-31-8425), 21 days (Hill et al., 2000) . Analysis of cardiac extracts from sham-operated and thoracic aorta-banded (TAB) MEK (PD98059), p38 (SB203580), cdk (olomoucine and roscovitine), or PI-3-kinase (rapamycin and wortmanmice showed that pressure overload increased HDAC kinase activity 2.1-and 1.7-fold, using GST-HDAC9 and nin). The kinase was also not inhibited by inhibitors of Figure 2B , at comparable multiplicities of infection (moi's), Ad-MITR S218/448A be predicted to inactivate HDACs and MITR, we tested whether mutant proteins lacking the regulatory phoswas more than twice as effective in suppressing ␤-MHC expression than wild-type MITR. The activity of Ad-MITR phorylation sites were able to prevent hypertrophic gene expression in primary rat cardiomyocytes. As shown in S218/448A in this assay is an underestimate of its relative potency because the mutant protein accumulates Figure 2A , the hypertrophic marker genes atrial natriuretic factor (ANF) and ␤-myosin heavy chain (␤-MHC) to a level about 10-fold lower than the wild-type protein at the same moi ( Figure 2C ). are upregulated in cardiomyocytes stimulated with the adrenergic agonist phenylephrine (PE), a potent inducer
To determine whether signal-resistant MITR changed the acetylation state of histones associated with fetal of hypertrophy. Infection of cardiomyocytes with adenoviruses that expressed HDAC5 and MITR with serinecardiac genes, we performed chromatin immunoprecipi- ANF in response to FBS, ET-1, ANGII, and insulin-like HDAC9 because among the class II HDACs, it is expressed at the highest levels in the heart and because growth factor-1 (IGF-1; Figure 3C ). These findings suggested that phosphorylation of the regulatory serines MITR, the primary product of the HDAC9 locus, was highly effective in suppressing hypertrophy in vitro. in MITR and HDAC5 was necessary for hypertrophy in response to diverse agonists.
The targeted mutation deleted most of exon 4 and all of exon 5, which encode residues 99-176 that encompass the MEF2 binding domain of the protein (Figures Generation of HDAC9 Mutant Mice To further investigate the potential involvement of class 4A-4C). HDAC9 mutant mice were obtained at predicted Mendelian ratios and showed no discernible pathologi-II HDACs as suppressors of cardiac hypertrophy in vivo, we inactivated the mouse HDAC9/MITR gene by homolcal or histological abnormalities at early age (data not shown). ogous recombination in ES cells and generated HDAC9 mutant mice (Figures 4A-4C) . We chose to focus on To confirm that the mutation created a null allele, we performed RT-PCR analysis using primers representing exon sequences within and surrounding the targeted deletion region ( Figure 4D ). Using primer P2 (from deleted exon 4) and P3 (from exon 6), we detected a PCR product in RNA from hearts of wild-type and HDAC9 ϩ/Ϫ mice, but not of HDAC9 Ϫ/Ϫ mice. In contrast, using primer P1 (from exon 3) and primer P3, RT-PCR products were detected in RNA samples from mice of all genotypes. In HDAC9 ϩ/Ϫ mice, products of 549 and 300 bp, corresponding to the wild-type and mutant transcripts, respectively, were detected, whereas in HDAC9 Ϫ/Ϫ mice, only the mutant transcript was detected ( Figure 4D ). These results suggest that replacement of exon 4 and exon 5 of HDAC9 with LacZ-Neo induced alternative splicing of the targeted allele, such that exon 3 was spliced to exon 6. This was confirmed by sequence analysis of RT-PCR products. Such splicing caused a frameshift and introduced two stop-codons immediately following exon 3 (data not shown). Thus, no functional HDAC9 or MITR protein is produced in homozygous mutants. Furthermore, due to such alternative splicing, the lacZ gene was not expressed in mutant mice (data not shown).
To determine whether other HDACs might be upregulated in mutant mice to compensate for the lack of HDAC9, we compared the expression of HDACs 1-8 in hearts from wild-type and mutant mice by RT-PCR. Transcripts encoding these other HDACs were expressed at normal levels in mutant hearts ( Figure 4E ).
HDAC9 Mutant Mice Develop Age-Dependent Cardiac Hypertrophy and Are Hypersensitive to Pressure Overload
Although HDAC9 mutant mice were initially normal, by eight months of age they developed cardiac hypertrophy and showed an average increase of 46% in heart weight/ body weight ratios compared to age-matched wild-type controls (P Ͻ 0.001; Figures 5A and 5B) . In contrast, at one month of age, there was no significant difference in cardiac mass between wild-type and HDAC9 Ϫ/Ϫ mice. Despite the lack of an overt phenotype in young HDAC9 Ϫ/Ϫ mice, we wondered whether they might be sensitized to hypertrophic stimuli, as would be predicted if HDAC9 was a suppressor of stress-induced signaling pathways. Since our earlier finding indicated that pressure overload stimulated a kinase that would inactivate class II HDACs, we compared the responses of wild- mutants showed a 220% increase in response to calwhich harbors a LacZ transgene controlled by three tandem copies of the MEF2 consensus binding site, to cineurin (P Ͻ 0.001; Figure 6B ). Massive hypertrophy was observed in the right and left ventricular walls and determine whether HDAC9 regulated the responsiveness of MEF2 to calcineurin signaling in the intact interventricular septum. Histological analysis demonstrated that the increase in cardiac mass was a reflection heart in vivo. This MEF2-LacZ transgene provides a read-out of MEF2 transcriptional activity and is only of the extreme hypertrophy of individual cardiomyocytes in HDAC9 mutant mice ( Figure 6A , lower image). HDAC9 ϩ/Ϫ basally active in the postnatal heart (Naya et al., 1999). In the absence of calcineurin signaling, the MEF2-mice showed an enhanced cardiac growth response to calcineurin that was intermediate between that of wilddependent reporter was expressed at low levels in both wild-type and HDAC9 mutant hearts. In contrast, MEF2 type and HDAC9 Ϫ/Ϫ littermates ( Figure 6B ). The enhanced hypertrophy of HDAC9 Ϫ/Ϫ hearts was mirrored activity was elevated in the hearts of ␣-MHC-calcineurin transgenic mice, and in the HDAC9 mutant, MEF2-LacZ by changes in fetal cardiac gene expression, as Northern blot analysis showed that transcripts for ANF, brain naexpression was activated to even higher levels in response to calcineurin signaling ( Figure 6D ). These findtriuretic peptide (BNP), and ␤-MHC were super-induced by calcineurin in the absence of HDAC9 ( Figure 6C) . ings demonstrate that MEF2 responds to signals for pathologic, but not physiologic hypertrophy and that We considered the possibility that the exaggerated response of HDAC9 Ϫ/Ϫ hearts to stress signaling might the responsiveness of MEF2 to calcineurin signaling is negatively regulated by HDAC9 in vivo. reflect subtle structural or functional cardiac abnormalities that are exacerbated by stress. However, echocardiography failed to reveal any abnormalities in cardiac function in HDAC9 mutant mice up to 8 months of age. Discussion We also considered whether noncardiac or systemic abnormalities could contribute to the sensitized phenoStress signals stimulate adult cardiomyocytes to undergo hypertrophy, which is associated with the activatype of HDAC9 mutants, but we observed no abnormalities in lung, vascular system, or skeletal muscle of the tion of a fetal cardiac gene program that results in maladaptive changes in cardiac contractility and calcium mutants. Thus, we conclude that the phenotype represents a cell-autonomous abnormality of cardiac myohandling. The results of this study show that stress signals stimulate an HDAC kinase that phosphorylates concytes.
served regulatory serine residues in class II HDACs. This sensitized phenotype also suggests that stress sigsuggests that this kinase integrates multiple hypertronals do not inactivate all the repressive activity of class phic signaling pathways. Of course, activation of HDAC II HDACs and that residual nonphosphorylated HDACs kinase activity by different hypertrophic stimuli need dampen the hypertrophic response. Otherwise, removnot be direct and could involve secondary pathways or ing HDAC9 would not be expected to augment the hyautocrine signaling loops. pertrophic response. While HDAC9 mutant mice show an enhanced reRepression of Cardiac Hypertrophy by MITR sponse to stress signals, they do not show abnormal and Class II HDACs cardiac growth during postnatal development when the The phenotype of HDAC9 mutant mice demonstrates heart enlarges through physiologic hypertrophy. That that this HDAC acts in the adult heart to suppress the simply eliminating HDAC activity is insufficient to cause fetal gene program and hypertrophic growth. In the abhypertrophy suggests that the hypertrophic program sence of stress, these mice showed normal cardiac size also requires positive signals that are likely to be diand function at young age, whereas at old age or when rected at other targets. (By analogy, releasing the brake stressed by pressure overload or calcineurin activation, of a car is insufficient to make it move without also they showed a severely exaggerated hypertrophic restepping on the accelerator.) It is notable in this regard sponse. Remarkably, deletion of only a single HDAC9 that MEF2 is activated by several stress response pathallele was sufficient to sensitize animals to hypertrophic ways through mechanisms independent of HDAC derestimuli, resulting in a cardiac growth response intermepression ( 
Mutant forms of class II HDACs that cannot be phos-

